Adrienne

Biography

Adrienne L. Graves, Ph.D. has served a member of Nicox’ board of directors since August 2014. Dr. Graves served as president and chief executive officer of Santen Inc., the U.S. branch of Santen Pharmaceutical Co., Ltd., from 1995 to 2010. Previously, she worked in various roles, including director of international ophthalmology at Alcon Laboratories, Inc. Dr. Graves is a member of the boards of directors of Akorn, Inc., Envisia Therapeutics Inc., Aerpio Pharmaceuticals, Inc., TearLab Corporation, the American Society of Cataract and Refractive Surgery and the Glaucoma Research Foundation, as well as an emeritus board member of the American Academy of Ophthalmology. Dr. Graves received her AB with honors in psychology from Brown University and her Ph.D. in psychobiology from the University of Michigan. She completed a postdoctoral fellowship in visual neuroscience at the University of Paris, France Adrienne L. Graves, Ph.D. has served a member of Nicox’ board of directors since August 2014. Dr. Graves served as president and chief executive officer of Santen Inc., the U.S. branch of Santen Pharmaceutical Co., Ltd., from 1995 to 2010. Previously, she worked in various roles, including director of international ophthalmology at Alcon Laboratories, Inc. Dr. Graves is a member of the boards of directors of Akorn, Inc., Envisia Therapeutics Inc., Aerpio Pharmaceuticals, Inc., TearLab Corporation, the American Society of Cataract and Refractive Surgery and the Glaucoma Research Foundation, as well as an emeritus board member of the American Academy of Ophthalmology. Dr. Graves received her AB with honors in psychology from Brown University and her Ph.D. in psychobiology from the University of Michigan. She completed a postdoctoral fellowship in visual neuroscience at the University of Paris, France

Research Interest

management and operational experience in the life sciences industry ophthalmology